Revolution Medicines (RVMD)
NASDAQ:RVMD

Revolution Medicines (RVMD) Stock Price & Analysis

137 Followers

RVMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$14.08 - $31.37
Previous Close$27.86
Volume615.55K
Average Volume (3M)973.09K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$655.01M
Total Debt (Recent Filing)$65.20M
Price to Earnings (P/E)-8.8
Beta0.69
Next EarningsFeb 28, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-3.18
Shares Outstanding88,790,799
R-Squared0.25
Standard Deviation0.18
10 Day Avg. Volume1,240,246
30 Day Avg. Volume973,093
Price to Book (P/B)4.03
Price to Sales (P/S)121.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-14.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside11.27% Upside
Rating ConsensusStrong Buy
Alpha-0.00715
Number of Analyst Covering3


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

RVMD FAQ

What was Revolution Medicines’s price range in the past 12 months?
Revolution Medicines lowest stock price was $14.08 and its highest was $31.37 in the past 12 months.
    What is Revolution Medicines’s market cap?
    Currently, no data Available
    When is Revolution Medicines’s upcoming earnings report date?
    Revolution Medicines’s upcoming earnings report date is Feb 28, 2023 which is in 32 days.
      How were Revolution Medicines’s earnings last quarter?
      Revolution Medicines released its earnings results on Nov 07, 2022. The company reported -$0.87 earnings per share for the quarter, missing the consensus estimate of -$0.842 by -$0.028.
        Is Revolution Medicines overvalued?
        According to Wall Street analysts Revolution Medicines’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Revolution Medicines pay dividends?
          Revolution Medicines does not currently pay dividends.
          What is Revolution Medicines’s EPS estimate?
          Revolution Medicines’s EPS estimate is -$0.82.
            How many shares outstanding does Revolution Medicines have?
            Revolution Medicines has 88,790,800 shares outstanding.
              What happened to Revolution Medicines’s price movement after its last earnings report?
              Revolution Medicines reported an EPS of -$0.87 in its last earnings report, missing expectations of -$0.842. Following the earnings report the stock price went down -0.607%.
                Which hedge fund is a major shareholder of Revolution Medicines?
                Among the largest hedge funds holding Revolution Medicines’s share is Deerfield Management Company, LP. It holds Revolution Medicines’s shares valued at 57M.

                  ---

                  Revolution Medicines Stock Smart Score

                  The Revolution Medicines stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Revolution Medicines

                  Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Arcus Biosciences
                  Relay Therapeutics
                  Akero Therapeutics
                  ProKidney
                  ImmunityBio

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis